Related Experiment Video
Updated: Jul 15, 2025
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Emerging Immunotherapy Approaches for Treating Prostate Cancer
Lingbin Meng1, Yuanquan Yang1, Amir Mortazavi1
1Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Immunotherapy shows promise for prostate cancer treatment, but efficacy is limited. Research focuses on immune checkpoint inhibitors, CAR T cells, and vaccines to improve outcomes for advanced disease.
Area of Science:
- Oncology
- Immunology
Background:
- Immunotherapy is a key cancer treatment, yet shows limited efficacy in prostate cancer.
- Prostate cancer requires novel therapeutic strategies to improve patient outcomes.
Purpose of the Study:
- To review current immunotherapy strategies for prostate cancer.
- To discuss preclinical rationale, clinical trial outcomes, and future directions for improving efficacy.
Main Methods:
- Literature review of immunotherapy modalities.
- Analysis of clinical trial data and ongoing research.
Main Results:
- Key strategies include immune checkpoint inhibitors, bispecific T cell-engaging antibodies, chimeric antigen receptor (CAR) T cells, therapeutic vaccines, and cytokines.
- Ongoing trials focus on biomarker discovery, resistance mechanisms, CAR T cell refinement, and early intervention.
Conclusions:
- Despite challenges, ongoing research in immunotherapy offers optimism for improved prostate cancer treatment options.
- Further development is crucial to realize the full clinical potential of immunotherapy in advanced prostate cancer.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...